[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.225.194.144. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1986

Pathologic Findings in Fetal GM1 Gangliosidosis

Author Affiliations

From the Department of Pathology, Brigham & Women's Hospital, Boston (Drs Bieber, Mortimer, and Driscoll); Harvard Medical School, Boston (Drs Bieber, Kolodny, and Driscoll); Children's Service (Dr Bieber) and Neurology Service (Dr Kolodny), Massachusetts General Hospital, Boston; and Department of Biochemistry, Eunice Kennedy Shriver Center for Mental Retardation, Waltham, Mass (Dr Kolodny).

Arch Neurol. 1986;43(7):736-738. doi:10.1001/archneur.1986.00520070090027
Abstract

• A 24-week fetus with GM1 gangliosidosis (type 1) was studied using biochemical and histopathologic methods. Foam cells in viscera and placenta demonstrated widespread accumulation of a lipidlike material. By microscopy, central nervous system storage appeared confined to the retina and dorsal root ganglia, but the brain ganglioside content was measurably elevated compared with that of age-matched controls. These data, along with those of others, imply that, if the observed pathologic findings are irreversible, any attempts at intrauterine therapy must commence prior to the middle of the second trimester.

×